| abstract |
Tumor necrosis factor antagonists are administered in a therapeutically effective amount for treating and / or preventing endometritis. Antagonists of the invention are generally selected from a wide variety of molecules, preferably soluble TNF receptors. Antagonists are used for the regression of endometritis lesions and, in combination with other active ingredients, are useful for alleviating related diseases (eg, infertility). |